Update from ASH 2020 on Aggressive NHL – Focus on DLBCL

Dr. Martin Hutchings – Rigshospitalet (Copenhagen, Denmark)

About Speaker

Dr. Martin Hutchings – Rigshospitalet

Dr Martin Hutchings is a haemato-oncologist and a senior consultant from the Department of Haematology, Rigshospitalet, Copenhagen University Hospital. He is responsible for lymphoma treatment and clinical research and for Denmark’s only dedicated Phase 1 unit for experimental treatment of haematological malignancies. After obtaining his medical degree and master’s degree (2000), he trained in nuclear medicine until pursuing his current specialisation in clinical oncology.  In 2006, he defended his PhD on PET/CT in Hodgkin lymphoma. Dr Hutchings is an active member of the EORTC Lymphoma Group, and chaired the group from 2013 until 2017. He leads a number of clinical and translational studies in the field of lymphoma, with an emphasis on phase 1 haematology studies and on phase 2 and 3 Hodgkin lymphoma and mantle cell lymphoma, while maintaining a special scientific interest in the role of molecular imaging of malignant lymphoma. He has written numerous journal articles and book chapters and acts as a supervisor for a dynamic group of PhD students.

Thank you to our WHU 2021 Sponsors